文献速递疼痛医学

肠道菌群调控疼痛:分子机制与治疗潜力

Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential.
PubMed 文献 · Br J Anaesth · 2019-09-21

本文为叙述性综述,总结肠道菌群在疼痛调控中的作用。菌群来源的代谢物、神经递质和神经调质等信号分子作用于受体,调节外周和中枢敏化,介导慢性疼痛发生。靶向肠道菌群(饮食和药物生物制剂干预)可能成为慢性疼痛管理的新策略。

要点

  • 肠道菌群是内脏痛的关键调节因素,也参与炎性痛、头痛、神经病理性疼痛和阿片耐受。
  • 菌群来源介质直接或间接调节初级伤害性神经元兴奋性,诱导外周敏化。
  • 菌群来源介质可能通过神经炎症调节中枢敏化的诱导和维持。

核心结论

  • 肠道菌群通过外周和中枢神经系统调节疼痛,靶向菌群可能成为慢性疼痛的新治疗策略。

研究设计与样本

  • 叙述性综述,总结当前关于肠道菌群在疼痛调控中作用的认识。

主要发现

  • 肠道菌群是内脏痛的关键调节因素,近期证据提示其也参与炎性痛、头痛、神经病理性疼痛和阿片耐受。
  • 菌群来源的信号分子(如菌群副产物、代谢物、神经递质和神经调质)作用于相应受体,显著调节外周和中枢敏化。
  • 菌群来源介质作为关键调节者诱导外周敏化,直接或间接调节初级伤害性神经元的兴奋性。
  • 在中枢神经系统,菌群来源介质可能调节神经炎症,涉及血脑屏障细胞、小胶质细胞和浸润免疫细胞的激活,以调节中枢敏化的诱导和维持。

临床怎么用

  • 通过饮食和药物生物制剂干预靶向肠道菌群,可能成为慢性疼痛管理的新治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The relationship between gut microbiota and neurological diseases, including chronic pain, has received increasing attention. The gut microbiome is a crucial modulator of visceral pain, whereas recent evidence suggests that gut microbiota may also play a critical role in many other types of chronic pain, including inflammatory pain, headache, neuropathic pain, and opioid tolerance. We present a narrative review of the current understanding on the role of gut microbiota in pain regulation and discuss the possibility of targeting gut microbiota for the management of chronic pain. Numerous signalling molecules derived from gut microbiota, such as by-products of microbiota, metabolites, neurotransmitters, and neuromodulators, act on their receptors and remarkably regulate the peripheral and central sensitisation, which in turn mediate the development of chronic pain. Gut microbiota-derived mediators serve as critical modulators for the induction of peripheral sensitisation, directly or indirectly regulating the excitability of primary nociceptive neurones. In the central nervous system, gut microbiota-derived mediators may regulate neuroinflammation, which involves the activation of cells in the blood-brain barrier, microglia, and infiltrating immune cells, to modulate induction and maintenance of central sensitisation. Thus, we propose that gut microbiota regulates pain in the peripheral and central nervous system, and targeting gut microbiota by diet and pharmabiotic intervention may represent a new therapeutic strategy for the management of chronic pain.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Guo R, Chen LH, Xing C, et al. Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential. Br J Anaesth. 2019. PMID: 31551115. doi:10.1016/j.bja.2019.07.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。